Viewing Study NCT05017103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2026-03-14 @ 4:04 AM
Study NCT ID: NCT05017103
Status: TERMINATED
Last Update Posted: 2024-12-11
First Post: 2021-08-17
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Undifferentiated Pleomorphic Sarcoma View
None Metastatic Undifferentiated Pleomorphic Sarcoma View
None Recurrent Undifferentiated Pleomorphic Sarcoma View
None Unresectable Undifferentiated Pleomorphic Sarcoma View
Keywords: